Authors

• Melinda Gooderham (ORCID: https://orcid.org/0000-0001-8926-0113)
• Jennifer Soung (ORCID: https://orcid.org/0009-0009-5586-0677)
• Kim Papp (ORCID: https://orcid.org/0000-0001-9557-3642)
• Jerry Bagel (ORCID: https://orcid.org/0000-0001-5241-0915)
• Javier Alonso‐Llamazares
• Patrick Burnett (ORCID: https://orcid.org/0000-0002-7123-9161)
• Lawrence Green (ORCID: https://orcid.org/0000-0002-9781-8700)
• Michael Bukhalo
• Leon Kircik (ORCID: https://orcid.org/0000-0002-0831-2151)
• Laura K. Ferris (ORCID: https://orcid.org/0000-0003-3000-2165)
• Melissa S. Seal
• Janet DuBois (ORCID: https://orcid.org/0000-0002-7487-7716)
• Scott Snyder (ORCID: https://orcid.org/0000-0002-3903-9792)
• David H. Chu (ORCID: https://orcid.org/0000-0001-7797-3829)
• Neal Bhatia (ORCID: https://orcid.org/0000-0001-7448-7809)
• Wei Jing Loo
• Saori Kato
• David R. Berk
• David Krupa
• Benjamin Lockshin

Institutions

• Western University (CA)
• University of Pittsburgh (US)
• University of Toronto (CA)
• George Washington University (US)
• Queen's University (CA)
• Clinical Research of South Florida (US)
• SKiN Health (CA)
• VA New Jersey Health Care System (US)
• Therapeutics Clinical Research (US)
• Arlington Dermatology (US)
• Probity Medical Research (CA)
• DermResearch (United States) (US)
• Atara Biotherapeutics (United States) (US)
• Gold Skin Care Center (US)
• Icahn School of Medicine at Mount Sinai (US)

Publication Details

Journal

JAMA Dermatology

Published

2025-05-07

DOI

https://doi.org/10.1001/jamadermatol.2025.1136

Citations

7

Primary Topic

Psoriasis: Treatment and Pathogenesis

Type

article

Field-Weighted Citation Impact

5.58

Funders

• Amgen
• Bristol-Myers Squibb
• Eli Lilly and Company
• Pfizer
• Sun Pharma